Blackwells Capital Activist Presentation Deck
BOARD OVERVIEW
Pamela J. Spackman INDEPENDENT TRUSTEE
Source: WPT Industrial Company Filings, Company Reports, FactSet.
BW BLACKWELLS CAPITAL
WPT's Board Member Biographies
Pam Spackman, a corporate director, currently serves on the board of Slate Office REIT and as Chair of Governance, Compensation
and Nominating Committee, and member of Audit Committee. Slate Office REIT is a TSX-listed enterprise focused on investing in office
properties in Canada. Ms. Spackman is also a member of the Advisory Committee, responsible for the valuation of the Limited
Partnership units, for Crestpoint Real Estate Investments Ltd. Crestpoint, is a part of the Connor, Clark and Lunn group of companies,
and owns a growing portfolio of approximately $2.5 billion of commercial properties on behalf of its limited partnership investors. She is
a member of the Independent Investment Committee of the Bentall Kennedy High Yield Canadian Property Fund. This fund invests in
high yield mortgage debt and real estate equity in Canada. It is sponsored by Bentall Kennedy and Sun Life Investment Management.
Ms. Spackman has previously served as Chair of the Timbercreek Mortgage Advisory Committee, from July 2008 until June 2016 (the
date of amalgamation of the three TSX-listed mortgage funds for which this committee reviewed and approved all mortgage
investments). She also served on the board of Gazit America Inc., and as Chair of Governance, Compensation and Nominating
Committee and a member of the Audit Committee from July 2009 until August 2012 (the date of its privatization and de-listing from the
TSX). Ms. Spackman served as President and CEO of Column Canada Financial Corporation, a wholly owned subsidiary of Credit
Suisse Group AG from July 2000 to July 2008. Prior to that, Pam served as Vice-President Mortgage Investments, at the Ministry of
Finance, Province of British Columbia (bcIMC) and an Investment Manager for the Workers' Compensation Board Investment Fund in
Ontario. Ms. Spackman acquired the ICD.D designation in 2010 following completion of the Institute of Corporate Directors programme
at University of Toronto.
Strictly Confidential & Trade Secret
71View entire presentation